BOOK
Topics in Cardiology, An Issue of Veterinary Clinics: Small Animal Practice - E-Book
(2010)
Additional Information
Book Details
Abstract
A comprehensive review of cardiology for the small animal practitioner! Articles will focus on advanced techniques in echocardiography, use of natiuretic peptides in the management of canine patients with heart disease, use of natiuretic peptides in the management of feline patients with heart disease, current use of pimobendan in canine patients with heart disease, canine mitral valve disease, infective endocarditis, interventional catheterization for congenital heart disease, pulmonary hypertension, feline hypertrophic cardiomyopathy, feline arrhythmias, surgery for cardiac disease, gene therapy for cardiac disease, and much more!
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Contributors | iii | ||
| Contents | v | ||
| FORTHCOMING ISSUES | ix | ||
| RECENT ISSUES | ix | ||
| Erratum | xi | ||
| Preface | xiii | ||
| Chapter 1. Advanced Techniques in Echocardiography in Small Animals | 529 | ||
| TISSUE DOPPLER IMAGING | 529 | ||
| TDI-DERIVED STRAIN AND STRAIN RATE IMAGING | 536 | ||
| TWO-DIMENSIONAL SPECKLE TRACKING ECHOCARDIOGRAPHY | 540 | ||
| SUMMARY | 541 | ||
| REFERENCES | 541 | ||
| Chapter 2. The Use of NT-proBNP Assay in the Management of Canine Patients with Heart Disease | 545 | ||
| THE BIOLOGY OF NT-proBNP | 545 | ||
| HOW BNP TESTING IS USED IN HUMAN MEDICINE | 546 | ||
| NT-proBNP TESTING IN DOGS WITH RESPIRATORY SIGNS | 547 | ||
| NT-proBNP TESTING IN DOGS SUSPECTED TO HAVE HEART DISEASE | 549 | ||
| NT-proBNP TESTING TO STRATIFY RISK | 550 | ||
| NT-proBNP TESTING TO GUIDE THERAPY | 552 | ||
| PRACTICALITIES AND LIMITATIONS OF NT-proBNP TESTING | 552 | ||
| THE FUTURE OF NATRIURETIC PEPTIDE TESTING | 554 | ||
| REFERENCES | 555 | ||
| Chapter 3. Natriuretic Peptides: The Feline Experience | 559 | ||
| HISTORICAL BACKGROUND | 559 | ||
| INTRODUCTION OF THE ELISA | 560 | ||
| ASSESSMENT OF CIRCULATING NATRIURETIC PEPTIDE CONCENTRATIONS IN CATS WITH MYOCARDIAL DISEASE | 560 | ||
| ASSESSMENT OF CIRCULATING NATRIURETIC PEPTIDE CONCENTRATIONS IN CATS WITH RESPIRATORY DISTRESS | 561 | ||
| OTHER FACTORS INFLUENCING CIRCULATING NATRIURETIC PEPTIDE CONCENTRATIONS | 563 | ||
| SAMPLE HANDLING | 563 | ||
| RENAL FUNCTION | 564 | ||
| BLOOD PRESSURE | 564 | ||
| OTHER FACTORS | 564 | ||
| NATRIURETIC PEPTIDES IN THE MANAGEMENT OF FELINE HEART DISEASE | 564 | ||
| SUMMARY | 566 | ||
| ACKNOWLEDGMENTS | 566 | ||
| REFERENCES | 566 | ||
| Chapter 4. Current Use of Pimobendan in Canine Patients with Heart Disease | 571 | ||
| DILATED CARDIOMYOPATHY | 571 | ||
| DMVD | 574 | ||
| WHAT EVIDENCE SUPPORTS THE USE OF PIMOBENDAN IN OTHER FORMS OF HEART DISEASE AND FAILURE? | 578 | ||
| SUMMARY | 578 | ||
| REFERENCES | 578 | ||
| Chapter 5. Minimally Invasive Per-Catheter Occlusion and Dilation Procedures for Congenital Cardiovascular Abnormalities in Dogs | 581 | ||
| OCCLUSION PROCEDURES FOR PATENT DUCTUS ARTERIOSUS | 582 | ||
| OCCLUSION PROCEDURES FOR OTHER CONGENITAL CARDIOVASCULAR DEFECTS | 593 | ||
| BALLOON DILATION OF PULMONIC STENOSIS | 596 | ||
| BALLOON DILATION OF OTHER OBSTRUCTIVE CONGENITAL CARDIOVASCULAR ABNORMALITIES | 598 | ||
| SUMMARY | 599 | ||
| REFERENCES | 600 | ||
| Chapter 6. Surgery for Cardiac Disease in Small Animals: Current Techniques | 605 | ||
| PREOPERATIVE ASSESSMENT | 606 | ||
| INFLOW OCCLUSION | 606 | ||
| CARDIOPULMONARY BYPASS | 607 | ||
| CONGENITAL HEART DEFECTS | 611 | ||
| ACQUIRED HEART DEFECTS | 616 | ||
| SUMMARY | 618 | ||
| ACKNOWLEDGMENTS | 618 | ||
| REFERENCES | 618 | ||
| Chapter 7. Pulmonary Hypertension in Dogs: Diagnosis and Therapy | 623 | ||
| CLASSIFICATION OF PULMONARY HYPERTENSION | 624 | ||
| SIGNALMENT AND CLINICAL SIGNS | 625 | ||
| PHYSICAL EXAMINATION | 625 | ||
| DIAGNOSIS | 625 | ||
| TREATMENT | 633 | ||
| SUMMARY | 636 | ||
| REFERENCES | 636 | ||
| Chapter 8. Feline Arrhythmias: An Update | 643 | ||
| HYPERKALEMIA | 643 | ||
| VENTRICULAR TACHYARRHYTHMIAS | 645 | ||
| AV BLOCK | 646 | ||
| HCM | 648 | ||
| SUMMARY | 649 | ||
| REFERENCES | 649 | ||
| Chapter 9. Canine Degenerative Myxomatous Mitral Valve Disease: Natural History, Clinical Presentation and Therapy | 651 | ||
| NATURAL HISTORY | 651 | ||
| DIAGNOSIS | 653 | ||
| CLINICAL PRESENTATION AND TREATMENT | 655 | ||
| SUMMARY | 659 | ||
| REFERENCES | 660 | ||
| Chapter 10. Infective Endocarditis in Dogs: Diagnosis and Therapy | 665 | ||
| OVERVIEW | 665 | ||
| PATHOGENESIS OF IE | 665 | ||
| CAUSATIVE AGENTS | 667 | ||
| IE CAUSED BY BARTONELLA | 667 | ||
| PREDISPOSING FACTORS | 669 | ||
| PATHOPHYSIOLOGY OF IE | 669 | ||
| TREATMENT OF CONGESTIVE HEART FAILURE | 680 | ||
| SUMMARY | 682 | ||
| ACKNOWLEDGMENTS | 682 | ||
| REFERENCES | 682 | ||
| Chapter 11. Feline Hypertrophic Cardiomyopathy: An Update | 685 | ||
| INTRODUCTION/HISTORICAL PERSPECTIVE | 685 | ||
| ETIOPATHOGENESIS | 686 | ||
| EPIDEMIOLOGY | 686 | ||
| PATHOPHYSIOLOGY OF HYPERTROPHIC CARDIOMYOPATHY | 688 | ||
| CLINICAL PRESENTATION | 691 | ||
| SCREENING FOR HCM | 692 | ||
| THERAPY | 694 | ||
| PROGNOSIS/NATURAL HISTORY | 695 | ||
| REFERENCES | 696 | ||
| Chapter 12. Genetics of Cardiac Disease in the Small Animal Patient | 701 | ||
| AUTOSOMAL RECESSIVE | 701 | ||
| AUTOSOMAL DOMINANT | 702 | ||
| X-LINKED | 703 | ||
| POLYGENIC | 703 | ||
| GENETIC PENETRANCE | 703 | ||
| MAKING BREEDING RECOMMENDATIONS | 703 | ||
| INHERITED CONGENITAL HEART DISEASE | 704 | ||
| ACQUIRED HEART DISEASE | 707 | ||
| ADULT-ONSET DISEASE IN THE DOG | 709 | ||
| VALVULAR DISEASE | 711 | ||
| SUMMARY | 712 | ||
| REFERENCES | 712 | ||
| Chapter 13. Status of Therapeutic Gene Transfer to Treat Canine Dilated Cardiomyopathy in Dogs | 717 | ||
| SUMMARY | 721 | ||
| REFERENCES | 721 | ||
| Index | 725 |